Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
Sexuality and gender diverse (LGBTQ+) people are a priority for cancer control due to differing experience of risk factors for cancer and participation in cancer screening services compared to cisg
This report presents the learnings of a project (hereafter referred to as the Project) which used an outcome-based commissioning process to develop, implement, and evaluate
Please visit the 'Interventions for substance use disorders' website.
This technical report outlines websites associated with various databases and organisations that could provide grey literature resources related to illicit drug use, blood borne virus, and coverage
This report documents the search strategy and findings from an overview of reviews on interventions for substance use.
Clinical research on psychedelic drugs in psychiatry that was abandoned at the end of the 1970s has undergone a revival over the past two decades.
This technical report is an update of the 2016 technical
There is a recognised opportunity for more systematic and timely triangulation of existing data to rapidly assess and identify emerging illicit drug trends in Australia.